Google announced today that it has licensed its AI research model for breast cancer screening to medical technology company iCAD. This is the first time Google is licensing the technology, with the hopes that it will eventually lead to more accurate breast cancer detection and risk assessment.
The two companies aim to eventually deploy the technology in real-world clinical settings — targeting a “2024 release,” Google communications manager Nicole Linton told The Verge in an email. Commercial deployment, however, still depends on how successful continued research and testing are. “We will move deliberately and test things as we go,” Linton said in the email.
Read more about this at theverge.com